Insider · CIK 0001304406

Glover Stephen C.

Reports to the SEC for 8 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001304406

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-01	ONCYONCOLYTICS BIOTECH INC · Stock OptionA Award	Director	AAward	+96K sh	—	—	96,000
2026-01-12	PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award	Director	AAward	+54.9K sh	—	—	54,876
2025-07-11	ZVSAZyVersa Therapeutics, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+137K sh	—	—	136,900
2025-06-11	PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award	Director	AAward	+22.7K sh	—	—	22,700
2025-02-28	PDSBPDS Biotechnology CorpP Purchase	Director	PPurchase	+15.1K sh	$1.66	+$25K	78,851
2025-02-28	PDSBPDS Biotechnology Corp · Common WarrantP Purchase	Director	PPurchase	+15.1K sh	—	—	15,061
2024-06-24	PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2024-03-07	Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−12.1K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−5,714 sh	—	—	0
2023-07-14	PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2023-06-07	Ambrx Biopharma Cayman, Inc.A Award	Director	AAward	+85K sh	—	—	85,000
2023-06-07	Ambrx Biopharma Cayman, Inc.Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-05-24	ZVSAZyVersa Therapeutics, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+1,627 sh	—	—	1,627
2023-05-18	Ambrx Biopharma Cayman, Inc.Stock Option (right to buy)A Award	Director	AAward	+210K sh	—	—	210,000
2023-05-18	Ambrx Biopharma Cayman, Inc.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Stock Options (right to buy)A Award	Director, Chief Executive Officer	AAward	+79.4K sh	—	—	79,417
2022-12-12	ZVSAZyVersa Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+449K sh	—	—	448,909
2022-12-12	ZVSAZyVersa Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+85.4K sh	—	—	85,442
2022-12-12	ZVSAZyVersa Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+49.6K sh	—	—	49,636
2022-12-12	ZVSAZyVersa Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+43.8K sh	—	—	43,847
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Series A Convertible Preferred StockA Award	Director, Chief Executive Officer	AAward	+18 sh	—	—	1,750
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Stock Options (right to buy)A Award	Director, Chief Executive Officer	AAward	+139K sh	—	—	138,980
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Stock Options (right to buy)A Award	Director, Chief Executive Officer	AAward	+169K sh	—	—	168,761
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Stock Options (right to buy)A Award	Director, Chief Executive Officer	AAward	+265K sh	—	—	264,838
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Stock Options (right to buy)A Award	Director, Chief Executive Officer	AAward	+126K sh	—	—	126,138
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Warrant (right to buy)A Award	Director, Chief Executive Officer	AAward	+70.9K sh	—	—	70,881
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Warrant (right to buy)A Award	Director, Chief Executive Officer	AAward	+3,022 sh	—	—	3,022
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Warrant (right to buy)A Award	Director, Chief Executive Officer	AAward	+17.9K sh	—	—	17,903
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Warrant (right to buy)A Award	Director, Chief Executive Officer	AAward	+1,750 sh	—	—	1,750
2022-06-28	PDSBPDS Biotechnology Corp · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2021-06-17	PDSBPDS Biotechnology Corp · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2021-06-15	PDSBPDS Biotechnology CorpP Purchase	Director	PPurchase	+5,882 sh	$8.50	+$50K	63,790
2020-06-23	PDSBPDS Biotechnology Corp · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2020-02-14	PDSBPDS Biotechnology CorpA Award	Director	AAward	+38.4K sh	$1.30	+$49.9K	57,908
2019-06-28	PDSBPDS Biotechnology Corp · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2009-03-31	INSMINSMED IncD Disposition to Issuer	President Follow-on Biologics	DDisposition to Issuer	−232K sh	$1.00	−$232K	368,845
2009-03-31	INSMINSMED IncM Exercise/Conversion	President Follow-on Biologics	MExercise/Conversion	+232K sh	—	—	601,226
2009-03-31	INSMINSMED Inc · Restricted Stock UnitsA Award	President Follow-on Biologics	AAward	+63.4K sh	—	—	532,381
2009-03-31	INSMINSMED IncF Tax Payment	President Follow-on Biologics	FTax Payment	−105K sh	$1.00	−$105K	372,113
2009-03-31	INSMINSMED IncA Award	President Follow-on Biologics	AAward	+108K sh	—	—	477,162
2009-03-31	INSMINSMED Inc · Restricted Stock UnitsM Exercise/Conversion	President Follow-on Biologics	MExercise/Conversion	−232K sh	—	—	300,000
2008-05-29	INSMINSMED IncA Award	President Follow-on Biologics	AAward	+289K sh	—	—	368,845
2008-05-29	INSMINSMED Inc · Restricted Stock UnitsA Award	President Follow-on Biologics	AAward	+169K sh	—	—	469,004
2007-06-25	INSMINSMED IncP Purchase	President Follow-on Biologics	PPurchase	+7,100 sh	$0.78	+$5,525.22	7,100
2007-06-25	INSMINSMED IncP Purchase	President Follow-on Biologics	PPurchase	+3,000 sh	$0.78	+$2,336.7	10,100
2007-06-25	INSMINSMED IncP Purchase	President Follow-on Biologics	PPurchase	+11.3K sh	$0.78	+$8,798.4	21,380
2007-06-25	INSMINSMED IncP Purchase	President Follow-on Biologics	PPurchase	+7,920 sh	$0.79	+$6,222.744	29,300
2007-06-25	INSMINSMED IncP Purchase	President Follow-on Biologics	PPurchase	+50.7K sh	$0.79	+$40.1K	80,000

Recent filings

Accepted (ET)
Jun 34
Glover Stephen C.0001493152-26-027100
SEC(opens sec.gov)
Mar 34
Glover Stephen C.0001140361-26-007639
SEC(opens sec.gov)
Jul 154
Glover Stephen C.0001641172-25-019725
SEC(opens sec.gov)
Jun 114
Glover Stephen C.0001140361-25-022223
SEC(opens sec.gov)
Mar 34
Glover Stephen C.0001140361-25-006783
SEC(opens sec.gov)
Jul 184
Glover Stephen C.0001493152-24-028404
SEC(opens sec.gov)
Jun 254
Glover Stephen C.0001140361-24-031293
SEC(opens sec.gov)
Mar 74
Glover Stephen C.0000950170-24-028188
SEC(opens sec.gov)
Jul 174
Glover Stephen C.0001140361-23-034831
SEC(opens sec.gov)
Jun 94
Glover Stephen C.0000899243-23-015185
SEC(opens sec.gov)
May 264
Glover Stephen C.0000899243-23-013994
SEC(opens sec.gov)
Dec 144
Glover Stephen C.0001493152-22-035479
SEC(opens sec.gov)

Companies

Address

C/O ONCOLYTICS BIOTECH INC. 4350 EXECUTIVE DRIVE, SUITE 325

SAN DIEGO, CA, 92121